Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.
Role Overview:
Senior Marketing Manager, Consumer Marketing
The Senior Marketing Manager, Consumer Marketing will take a leading role in the development and execution of NASH patient marketing assets, including content and tactical development, along with their review and approval. This position offers the unique opportunity to contribute to the commercial success of resmetirom, a first-to-market therapeutic with blockbuster potential, by educating and engaging NASH patients.
Working closely with the Brand Directors and cross-functional teams, this individual will lead the creation of compelling patient marketing materials that is aligned to our brand strategy and that effectively communicates the key value propositions of the brand and in patient-friendly language. The content will focus on disease education, promotional product education, patient resources, and will be leveraged across multiple channels, including digital (incl video) and print. This role is critical in ensuring the consistent and impactful representation of the brand in front of patients.
Position Responsibilities:
- Develop and implement consumer marketing materials that highlights the key benefits of resmetirom and supporting disease awareness initiatives.
- Lead the creation of consumer marketing assets (disease education and promotional materials), including development, review, approval that aligns with brand positioning, messaging, and regulatory guidelines.
- Collaborate with cross-functional partners (e.g., medical affairs, clinical, regulatory, market research) to ensure scientific accuracy and brand consistency, all while using patient-friendly language.
- Manage the content lifecycle, from initial concept through final approval, ensuring timely delivery to meet aggressive deadlines
- Ensure all content adheres to FDA regulations, industry standards, and company guidelines, while meeting the needs of the target patient audience.
- Use insights to refine marketing strategies for future assets.
- Stay informed about industry trends and competitor activities, identifying opportunities for differentiation
- Some travel is required – not more than 20% of the time
Qualifications and Skills Required:
- Self-motivated, independent thinker with a proven ability to develop high-quality, impactful marketing materials
- Strong project management skills with the ability to manage multiple projects simultaneously while meeting tight deadlines.
- Exceptional communication skills, with the ability to translate clinical data into clear, engaging messages for patients.
- Experience working cross-functionally to ensure alignment with key internal and external stakeholders.
- Strong attention to detail, ensuring accuracy and compliance with industry regulations
- Comfortable working in a fast-paced environment
- Required to be in office 3 days per week (Conshohocken, PA or Waltham, MA)
Education and Experience
- Bachelor’s degree required; MBA or Master’s degree preferred.
- 5+ years of biopharmaceutical consumer marketing or agency experience (required).
- Experience working with cross-functional teams, including medical, legal, and regulatory stakeholders.
- Strong experience in digital marketing, video, and multimedia content development is a plus.
Compensation:
Base salary is determined by several factors that include, but are not limited to, a successful candidate's qualifications, skills, education, experience, business needs, and market demands. The role may also be eligible for bonus, equity, and comprehensive benefits, which include flexible paid time off (PTO), medical, dental, vision, and life and disability insurance.
Top Skills
What We Do
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com